Search research articles
Contact Us
Filters
Showing results (151-160 of 264) with videos related to
Page
of 27
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 27, 2019
Cyclin E1 Expression and Palbociclib Efficacy in Previously Treated Hormone Receptor-Positive Metastatic Breast Cancer
Nicholas C Turner, Yuan Liu, Zhou Zhu, et al.
Breast Cancer Research and Treatment
|
October 23, 2008
Increasing steroid hormone receptors expression defines breast cancer subtypes non responsive to preoperative chemotherapy
Marco Colleoni, Vincenzo Bagnardi, Nicole Rotmensz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 14, 2007
Cardiovascular adverse events during adjuvant endocrine therapy for early breast cancer using letrozole or tamoxifen: safety analysis of BIG 1-98 trial
Henning Mouridsen, Aparna Keshaviah, Alan S Coates, et al.
Breast Cancer Research and Treatment
|
August 13, 2020
Treatment effect of palbociclib plus endocrine therapy by prognostic and intrinsic subtype and biomarker analysis in patients with bone-only disease: a joint analysis of PALOMA-2 and PALOMA-3 clinical trials
Richard S Finn, Massimo Cristofanilli, Johannes Ettl, et al.
Breast (Edinburgh, Scotland)
|
March 10, 2023
Tailoring the optimal duration of the extended adjuvant endocrine therapy in patients with early-stage breast cancer. A systematic review and meta-analysis of randomized clinical trials
Laura Pala, Tommaso De Pas, Eleonora Pagan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 25, 2016
Treatment Adherence and Its Impact on Disease-Free Survival in the Breast International Group 1-98 Trial of Tamoxifen and Letrozole, Alone and in Sequence
Jacquie H Chirgwin, Anita Giobbie-Hurder, Alan S Coates, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 31, 2023
Fine-Tuning Adjuvant Endocrine Therapy for Early-Stage Breast Cancer: An Expert Consensus on Open Issues for Future Research
Fabio Conforti, Laura Pala, Tommaso De Pas, et al.
JAMA Oncology
|
June 15, 2018
Association of Somatic Driver Alterations With Prognosis in Postmenopausal, Hormone Receptor-Positive, HER2-Negative Early Breast Cancer: A Secondary Analysis of the BIG 1-98 Randomized Clinical Trial
Stephen J Luen, Rebecca Asher, Chee Khoon Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 29, 2015
Relative Effectiveness of Letrozole Compared With Tamoxifen for Patients With Lobular Carcinoma in the BIG 1-98 Trial
Otto Metzger Filho, Anita Giobbie-Hurder, Elizabeth Mallon, et al.
Breast Cancer Research and Treatment
|
July 14, 2010
Pathological complete response after preoperative systemic therapy and outcome: relevance of clinical and biologic baseline features
Emilia Montagna, Vincenzo Bagnardi, Nicole Rotmensz, et al.
Page
of 27
Search research articles
Search
Showing results (151-160 of 264) with videos related to
Sort By:
Page
of 27
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 27, 2019
Cyclin E1 Expression and Palbociclib Efficacy in Previously Treated Hormone Receptor-Positive Metastatic Breast Cancer
Nicholas C Turner, Yuan Liu, Zhou Zhu, et al.
Breast Cancer Research and Treatment
|
October 23, 2008
Increasing steroid hormone receptors expression defines breast cancer subtypes non responsive to preoperative chemotherapy
Marco Colleoni, Vincenzo Bagnardi, Nicole Rotmensz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 14, 2007
Cardiovascular adverse events during adjuvant endocrine therapy for early breast cancer using letrozole or tamoxifen: safety analysis of BIG 1-98 trial
Henning Mouridsen, Aparna Keshaviah, Alan S Coates, et al.
Breast Cancer Research and Treatment
|
August 13, 2020
Treatment effect of palbociclib plus endocrine therapy by prognostic and intrinsic subtype and biomarker analysis in patients with bone-only disease: a joint analysis of PALOMA-2 and PALOMA-3 clinical trials
Richard S Finn, Massimo Cristofanilli, Johannes Ettl, et al.
Breast (Edinburgh, Scotland)
|
March 10, 2023
Tailoring the optimal duration of the extended adjuvant endocrine therapy in patients with early-stage breast cancer. A systematic review and meta-analysis of randomized clinical trials
Laura Pala, Tommaso De Pas, Eleonora Pagan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 25, 2016
Treatment Adherence and Its Impact on Disease-Free Survival in the Breast International Group 1-98 Trial of Tamoxifen and Letrozole, Alone and in Sequence
Jacquie H Chirgwin, Anita Giobbie-Hurder, Alan S Coates, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 31, 2023
Fine-Tuning Adjuvant Endocrine Therapy for Early-Stage Breast Cancer: An Expert Consensus on Open Issues for Future Research
Fabio Conforti, Laura Pala, Tommaso De Pas, et al.
JAMA Oncology
|
June 15, 2018
Association of Somatic Driver Alterations With Prognosis in Postmenopausal, Hormone Receptor-Positive, HER2-Negative Early Breast Cancer: A Secondary Analysis of the BIG 1-98 Randomized Clinical Trial
Stephen J Luen, Rebecca Asher, Chee Khoon Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 29, 2015
Relative Effectiveness of Letrozole Compared With Tamoxifen for Patients With Lobular Carcinoma in the BIG 1-98 Trial
Otto Metzger Filho, Anita Giobbie-Hurder, Elizabeth Mallon, et al.
Breast Cancer Research and Treatment
|
July 14, 2010
Pathological complete response after preoperative systemic therapy and outcome: relevance of clinical and biologic baseline features
Emilia Montagna, Vincenzo Bagnardi, Nicole Rotmensz, et al.
Page
of 27